名叫CelLBxHealth的CelLBxHealth, 名叫Peter Collins CEO, 新增董事; Renalytix 扩大了美国测试准入; Helix 高级Montana helium项目; Quadrise 扩展乳化剂交易。 CelLBxHealth named Peter Collins CEO, added directors; Renalytix expanded U.S. test access; Helix advanced Montana helium project; Quadrise extended emulsifier deal.

CelLBxHealth任命Peter Collins为首席执行官,并增加了三名新的非执行董事,加强了其在癌症诊断方面的领导作用。 CelLBxHealth appointed Peter Collins as CEO and added three new non-executive directors, strengthening its leadership in cancer diagnostics. Renalytix扩大了其美国足迹,建立了三个新的临床伙伴关系,使得能够通过纽约、佛罗里达和田纳西的电子健康记录进行直接测试,加速获得经林业发展局批准的肾病检测。 Renalytix expanded its U.S. footprint with three new clinical partnerships, enabling direct test ordering via electronic health records in New York, Florida, and Tennessee, accelerating access to its FDA-approved kidney disease test. Helix Exploration在蒙大拿州的Rudyard氦气项目取得了进展，包括交付关键压缩机和加深Inez-1井以进行岩心采样，首批氦气生产计划很快。 Helix Exploration made progress on its Rudyard helium project in Montana, including delivery of a key compressor and deepening of the Inez-1 well for core sampling, with first helium production targeted soon. 四方将其与Nouryon的乳化剂协定延长至2026年10月,支持其低排放燃料开发。 Quadrise extended its emulsifier agreement with Nouryon through October 2026, supporting its low-emission fuel development.